EMA probes AstraZeneca link to new blood vessel condition
Source: Read Full Article
The active ingredient Remdesivir is approved for use in Europe, subject to conditions as the first agent for the therapy […]EMA
Remdesivir as Covid-19-approved drug: Thus, the agent can help